Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Sequential Two Phase Multicenter, Randomized Study to Optimize Dose Selection and Evaluate Safety After Treatment With the Holaira™ Lung Denervation System in Patients With Moderate to Severe COPD.

NCT02058459 is registered in ClinicalTrials.gov with Nuvaira, Inc. as lead sponsor.

NCT NCT02058459
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02058459 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Sequential Two Phase Multicenter, Randomized Study to Optimize Dose Selection and Evaluate Safety After Treatment With the Holaira™ Lung Denervation System in Patients With Moderate to Severe COPD.
Lead sponsor
Nuvaira, Inc.
Phase
Not applicable
Overall status
Completed
Start date
August 4, 2014
Completion date
June 16, 2020
Enrollment
128 (actual)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

chronic obstructive pulmonary disease (copd)